<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss1full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.nature.com/~d/styles/itemcontent.css"?><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/" xmlns:admin="http://webns.net/mvcb/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">
<channel rdf:about="http://www.nature.com/nrclinonc/current_issue/rss">
<title>Nature Reviews Clinical Oncology - AOP - nature.com science feeds</title>
<description>Nature Reviews Clinical Oncology provides physicians and academics with authoritative and topical discussions of key developments in the field.</description>
<link>http://www.nature.com/nrclinonc/current_issue/</link>
<admin:generatorAgent rdf:resource="http://www.nature.com/" />
<admin:errorReportsTo rdf:resource="mailto:feedback@nature.com" />
<dc:publisher>Nature Publishing Group</dc:publisher>
<dc:language>en</dc:language>
<dc:rights>©  Nature Publishing Group</dc:rights>
<prism:publicationName>Nature Reviews Clinical Oncology</prism:publicationName>
<prism:issn>1759-4774</prism:issn>
<prism:eIssn>1759-4782</prism:eIssn>
<prism:copyright>©  Nature Publishing Group</prism:copyright>
<prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
<image rdf:resource="http://www.nature.com/includes/rj_globnavimages/nrclinonc_logo.gif" />
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrclinonc.2009.167" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrclinonc.2009.169" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrclinonc.2009.165" />
</rdf:Seq>
</items>
<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.nature.com/nrclinonc/rss/aop" type="application/rss+xml" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /></channel>
<image rdf:about="http://www.nature.com/includes/rj_globnavimages/nrclinonc_logo.gif">
<title>Nature Reviews Clinical Oncology</title>
<url>http://www.nature.com/includes/rj_globnavimages/nrclinonc_logo.gif</url>
<link>http://www.nature.com/nrclinonc/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1038/nrclinonc.2009.167">
<title>Primary HPV screening for cervical cancer prevention: results from European trials</title>
<link>http://feeds.nature.com/~r/nrclinonc/rss/aop/~3/_UHIRSujXnE/nrclinonc.2009.167</link>
<description>Six European randomized controlled trials that will compare human papillomavirus (HPV) testing with cytology testing for cervical screening are under way. The outcome of HPV testing versus cytology testing depends not only on the relative accuracy of the primary test but also on how radical the different triage procedures are. Two trials have shown a 50% reduction in grade 3 cervical intraepithelial neoplasia detection in subsequent screening rounds. The authors critically discuss the reasons for the different results observed in these trials and the implications for primary screening.</description>
<content:encoded><![CDATA[

<p>
<b>Primary HPV screening for cervical cancer prevention: results from European trials</b>
</p>
<p>Nature Reviews Clinical Oncology. <a href="http://dx.doi.org/10.1038/nrclinonc.2009.167">doi:10.1038/nrclinonc.2009.167</a>
</p>
<p>Authors: Elsebeth Lynge &amp; Matejka Rebolj</p>
<img src="http://feeds.feedburner.com/~r/nrclinonc/rss/aop/~4/_UHIRSujXnE" height="1" width="1"/>]]></content:encoded>
<dc:title>Primary HPV screening for cervical cancer prevention: results from European trials</dc:title>
<dc:creator>Elsebeth Lynge</dc:creator>
<dc:creator>Matejka Rebolj</dc:creator>
<dc:identifier>doi:10.1038/nrclinonc.2009.167</dc:identifier>
<dc:source>Nature Reviews Clinical Oncology</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Nature Reviews Clinical Oncology</prism:publicationName>
<prism:publicationDate>2009-11-10</prism:publicationDate>
<prism:doi>10.1038/nrclinonc.2009.167</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrclinonc.2009.167</prism:url>
<prism:section>Review</prism:section>
<prism:startingPage />
<prism:endingPage />
<feedburner:origLink>http://dx.doi.org/10.1038/nrclinonc.2009.167</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrclinonc.2009.169">
<title>Gamma-delta T-cell lymphomas</title>
<link>http://feeds.nature.com/~r/nrclinonc/rss/aop/~3/KTUUofkAuKU/nrclinonc.2009.169</link>
<description>Gamma-delta lymphomas are rare and aggressive lymphomas with a poor prognosis. The authors of this Review discuss the clinical and biological features of the two types of such lymphomas and the diagnostic challenges associated with these still insufficiently known diseases.</description>
<content:encoded><![CDATA[

<p>
<b>Gamma-delta T-cell lymphomas</b>
</p>
<p>Nature Reviews Clinical Oncology. <a href="http://dx.doi.org/10.1038/nrclinonc.2009.169">doi:10.1038/nrclinonc.2009.169</a>
</p>
<p>Authors: Claudio Tripodo, Emilio Iannitto, Ada Maria Florena, Carlo Ennio Pucillo, Pier Paolo Piccaluga, Vito Franco &amp; Stefano Aldo Pileri</p>
<img src="http://feeds.feedburner.com/~r/nrclinonc/rss/aop/~4/KTUUofkAuKU" height="1" width="1"/>]]></content:encoded>
<dc:title>Gamma-delta T-cell lymphomas</dc:title>
<dc:creator>Claudio Tripodo</dc:creator>
<dc:creator>Emilio Iannitto</dc:creator>
<dc:creator>Ada Maria Florena</dc:creator>
<dc:creator>Carlo Ennio Pucillo</dc:creator>
<dc:creator>Pier Paolo Piccaluga</dc:creator>
<dc:creator>Vito Franco</dc:creator>
<dc:creator>Stefano Aldo Pileri</dc:creator>
<dc:identifier>doi:10.1038/nrclinonc.2009.169</dc:identifier>
<dc:source>Nature Reviews Clinical Oncology</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Nature Reviews Clinical Oncology</prism:publicationName>
<prism:publicationDate>2009-11-10</prism:publicationDate>
<prism:doi>10.1038/nrclinonc.2009.169</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrclinonc.2009.169</prism:url>
<prism:section>Review</prism:section>
<prism:startingPage />
<prism:endingPage />
<feedburner:origLink>http://dx.doi.org/10.1038/nrclinonc.2009.169</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrclinonc.2009.165">
<title>Liver metastases from colorectal cancer: radioembolization with systemic therapy</title>
<link>http://feeds.nature.com/~r/nrclinonc/rss/aop/~3/sBcDtbH7Ubw/nrclinonc.2009.165</link>
<description>Most patients with advanced colorectal cancer die from hepatic metastases. Radioembolization is a technique for administering radiotherapy internally to unresectable primary or secondary hepatic malignancies in a single procedure to improve local control of disease. This technique enables significant downsizing of liver metastases to permit subsequent resection. The rationale for this approach combined with cytotoxic and molecularly targeted agents is discussed.</description>
<content:encoded><![CDATA[

<p>
<b>Liver metastases from colorectal cancer: radioembolization with systemic therapy</b>
</p>
<p>Nature Reviews Clinical Oncology. <a href="http://dx.doi.org/10.1038/nrclinonc.2009.165">doi:10.1038/nrclinonc.2009.165</a>
</p>
<p>Authors: Nils H. Nicolay, David P. Berry &amp; Ricky A. Sharma</p>
<img src="http://feeds.feedburner.com/~r/nrclinonc/rss/aop/~4/sBcDtbH7Ubw" height="1" width="1"/>]]></content:encoded>
<dc:title>Liver metastases from colorectal cancer: radioembolization with systemic therapy</dc:title>
<dc:creator>Nils H. Nicolay</dc:creator>
<dc:creator>David P. Berry</dc:creator>
<dc:creator>Ricky A. Sharma</dc:creator>
<dc:identifier>doi:10.1038/nrclinonc.2009.165</dc:identifier>
<dc:source>Nature Reviews Clinical Oncology</dc:source>
<dc:date>2009-11-03</dc:date>
<prism:publicationName>Nature Reviews Clinical Oncology</prism:publicationName>
<prism:publicationDate>2009-11-03</prism:publicationDate>
<prism:doi>10.1038/nrclinonc.2009.165</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrclinonc.2009.165</prism:url>
<prism:section>Review</prism:section>
<prism:startingPage />
<prism:endingPage />
<feedburner:origLink>http://dx.doi.org/10.1038/nrclinonc.2009.165</feedburner:origLink></item>
</rdf:RDF>
